Literature DB >> 29981373

Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis.

Simona Zanotti1, Sara Gibertini1, Flavia Blasevich1, Cinzia Bragato2, Alessandra Ruggieri1, Simona Saredi1, Marco Fabbri3, Pia Bernasconi1, Lorenzo Maggi1, Renato Mantegazza1, Marina Mora4.   

Abstract

Exosomes, natural carriers of mRNAs, non-coding RNAs and proteins between donor and recipient cells, actively contribute to cell-cell communication. We investigated the potential pro-fibrotic role of exosomes released by muscle-derived fibroblasts of Duchenne muscular dystrophy (DMD) patients, and of miRNAs carried by exosomes. By fibrosis focused array analysis we found that exosomes from DMD fibroblasts, had significantly higher levels of miR-199a-5p, a miRNA up-regulated in fibrotic conditions, compared to control exosomes, while levels in myoblast-derived exosomes were not increased. In control fibroblasts, exposure to DMD fibroblast-derived exosomes induced a myofibroblastic phenotype with increase in α-smooth actin, collagen and fibronectin transcript and protein expression, soluble collagen production and deposition, cell proliferation, and activation of Akt and ERK signaling, while exposure to control exosomes did not. Transfecting control fibroblasts or loading control exosomes with miR-199a-5p mimic or inhibitor induced opposing effects on fibrosis-related mRNAs and proteins, on collagen production and Akt and ERK pathways. Finally, injection of DMD fibroblast-derived exosomes into mouse tibialis anterior muscle after cardiotoxin-induced necrosis, produced greater fibrosis than control exosomes. Our findings indicate that exosomes produced by local fibroblasts in the DMD muscle are able to induce phenotypic conversion of normal fibroblasts to myofibroblasts thereby increasing the fibrotic response. This conversion is related to transfer of high levels of miR-199a-5p and to reduction of its target caveolin-1; both, therefore, are potential therapeutic targets in muscle fibrosis.
Copyright © 2018 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscle dystrophy; Exosomes; Fibroblasts; Fibrosis; Myofibroblasts; miRNAs

Mesh:

Substances:

Year:  2018        PMID: 29981373     DOI: 10.1016/j.matbio.2018.07.003

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  22 in total

1.  Soluble Insulin Receptor Levels in Plasma, Exosomes, and Urine and Its Association With HIV-Associated Neurocognitive Disorders.

Authors:  Yisel M Cantres-Rosario; Valerie Wojna; Rafael Ruiz; Bexaida Diaz; Miriam Matos; Rosa J Rodriguez-Benitez; Elaine Rodriguez; Richard L Skolasky; Yamil Gerena
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

2.  Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect.

Authors:  Eda Sun; Erdal Karaoz
Journal:  Am J Stem Cells       Date:  2020-08-25

Review 3.  Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.

Authors:  Alicja Starosta; Patryk Konieczny
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

4.  Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling.

Authors:  Melanie Gartz; Ashley Darlington; Muhammed Zeeshan Afzal; Jennifer L Strande
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

Review 5.  Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair.

Authors:  Muhammad Nawaz; Neelam Shah; Bruna Riedo Zanetti; Marco Maugeri; Renata Nacasaki Silvestre; Farah Fatima; Luciano Neder; Hadi Valadi
Journal:  Cells       Date:  2018-10-13       Impact factor: 6.600

6.  Senescent HUVECs-secreted exosomes trigger endothelial barrier dysfunction in young endothelial cells.

Authors:  Pooi-Fong Wong; Kind-Leng Tong; Juliana Jamal; Eng-Soon Khor; Siew-Li Lai; Mohd Rais Mustafa
Journal:  EXCLI J       Date:  2019-09-03       Impact factor: 4.068

7.  BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs.

Authors:  Jiahui Jin; Qingjian Ou; Zhe Wang; Haibin Tian; Jing-Ying Xu; Furong Gao; Shuqin Hu; Jie Chen; Juan Wang; Jieping Zhang; Lixia Lu; Caixia Jin; Guo-Tong Xu; Jingjun Zhao
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

8.  miR-29a is a potential protective factor for fibrogenesis in gluteal muscle contracture.

Authors:  R Zhou; S Ren; C Li; X Zhang; W Zhang
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

Review 9.  miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.

Authors:  Heather C Hrach; Marco Mangone
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

10.  Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.

Authors:  Melanie Gartz; Margaret Beatka; Mariah J Prom; Jennifer L Strande; Michael W Lawlor
Journal:  Hum Mol Genet       Date:  2021-11-16       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.